Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University again joined GRACE to discuss updates to the basics of lung cancer. In this (audio only, Spanish language) webcast for the Spanish lung cancer video library, Dr. Raez discusses PDL1 as a biomarker for second-line treatment.
RAEZ PDL1como biomarcador para segundo tratamiento [720p]
